No price history available.
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 3,922 | 4,299 | 4,681 | 5,198 | N/A | N/A | N/A | N/A |
| Operating profit | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | €m | 160 | 65 | -4,027 | 1,355 | N/A | N/A | N/A | N/A |
| EPS reported | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
ORPEA S.A. is a prominent healthcare provider specializing in the operation of diverse care facilities, including nursing homes, assisted-living residences, post-acute and rehabilitation hospitals, and psychiatric clinics. Within its nursing homes, the company delivers personalized support alongside comprehensive residential services, encompassing accommodation, dining, laundry, and housekeeping. These facilities also offer a rich program of daily activities, entertainment, and therapeutic engagements. Their post-acute and rehabilitation centers deliver specialized care for recovery from a wide array of conditions, encompassing geriatric needs, musculoskeletal and neurological disorders, cardiovascular and hematological issues, oncology, and support for patients in persistent vegetative or minimally conscious states. Psychiatric hospitals address a broad spectrum of mental health conditions, such as mood and anxiety disorders, obsessive-compulsive disorders, addictions, eating and sleep disorders, personality disorders, age-related psychiatric illnesses, psychosis, as well as syndromes like burnout, chronic fatigue, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder. They cater to diverse patient populations, including geriatric, pediatric, adolescent, and parent-child demographics, through both public and private services. Beyond facility-based care, ORPEA S.A. extends its offerings to home care, providing domestic assistance like cleaning, meal preparation, ironing, gardening, and running errands. This is complemented by daily living support, such as day or night supervision, personal hygiene aid, and mealtime assistance, alongside mobility support services. With a substantial international footprint, the company conducts its operations across more than two dozen countries, including France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. Established in 1989, ORPEA S.A. maintains its corporate headquarters in Puteaux, France.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
ORPEA S.A. is a prominent healthcare provider specializing in the operation of diverse care facilities, including nursing homes, assisted-living residences, post-acute and rehabilitation hospitals, and psychiatric clinics. Within its nursing homes, the company delivers personalized support alongside comprehensive residential services, encompassing accommodation, dining, laundry, and housekeeping. These facilities also offer a rich program of daily activities, entertainment, and therapeutic engagements. Their post-acute and rehabilitation centers deliver specialized care for recovery from a wide array of conditions, encompassing geriatric needs, musculoskeletal and neurological disorders, cardiovascular and hematological issues, oncology, and support for patients in persistent vegetative or minimally conscious states. Psychiatric hospitals address a broad spectrum of mental health conditions, such as mood and anxiety disorders, obsessive-compulsive disorders, addictions, eating and sleep disorders, personality disorders, age-related psychiatric illnesses, psychosis, as well as syndromes like burnout, chronic fatigue, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder. They cater to diverse patient populations, including geriatric, pediatric, adolescent, and parent-child demographics, through both public and private services. Beyond facility-based care, ORPEA S.A. extends its offerings to home care, providing domestic assistance like cleaning, meal preparation, ironing, gardening, and running errands. This is complemented by daily living support, such as day or night supervision, personal hygiene aid, and mealtime assistance, alongside mobility support services. With a substantial international footprint, the company conducts its operations across more than two dozen countries, including France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. Established in 1989, ORPEA S.A. maintains its corporate headquarters in Puteaux, France.
